Overview

SS‑31 is a synthetic, cell‑permeable tetrapeptide widely referenced in scientific literature for its selective interaction with mitochondrial membranes. In non‑clinical research settings, SS‑31 has been examined for its association with cardiolipin‑rich regions of the inner mitochondrial membrane and its relationship to mitochondrial structure, electron transport organization, and oxidative stress–related readouts.

All descriptions of SS‑31 are derived exclusively from controlled in‑vitro systems and preclinical in‑vivo model studies and are limited to laboratory investigation.

Research Applications

SS‑31 is utilized in experimental workflows focused on mitochondrial biology and cellular energetics. Reported non‑clinical research contexts include:

• Mitochondrial membrane integrity studies — evaluation of inner membrane stabilization and ultrastructural organization
• Oxidative stress research — assessment of reactive oxygen species (ROS)–associated molecular markers
• Electron transport chain–associated assays — investigation of respiratory complex organization and efficiency
• Cellular bioenergetics analysis — ATP production, mitochondrial membrane potential, and metabolic flux endpoints
• Cardiac, skeletal muscle, and neural cell model studies — mitochondrial‑associated markers evaluated under controlled laboratory stress conditions

All reported applications remain confined to descriptive and mechanistic research in controlled laboratory environments.

Pathway & Mechanistic Context

Preclinical publications describe SS‑31 as a mitochondria‑targeted peptide with affinity for cardiolipin, a phospholipid critical for inner mitochondrial membrane organization. Through this association, SS‑31 has been studied in relation to mitochondrial cristae structure, respiratory chain assembly, and oxidative signaling balance in experimental systems.

Mechanistic observations focus on biochemical and molecular endpoints and do not imply functional or therapeutic outcomes outside of laboratory study conditions.

Preclinical Research Summary

Across cellular and animal model systems, SS‑31 has been evaluated using endpoints such as mitochondrial morphology, oxidative damage markers, respiration‑linked parameters, and gene‑expression changes under defined experimental protocols. These observations are reported solely within non‑clinical research frameworks.

Product Specifications

Handling & Storage

• Store at −20 °C in a dry environment.
• Protect from light and moisture.
• Allow vial to equilibrate to room temperature prior to opening to minimize condensation.
• Reconstitute using sterile laboratory techniques where applicable.

Intended Research Use

• For in‑vitro and preclinical laboratory research only.
• Intended for use by qualified professionals in controlled research environments.

Disclaimer

This product is sold For Research Use Only (RUO).

Not for human or animal consumption.

Not approved for diagnostic, therapeutic, medical, or veterinary use.

Important Legal & Educational Notice

This document is provided solely for general educational and informational purposes. It does NOT provide medical advice, legal advice, dosing guidance, treatment instructions, or recommendations of any kind. Nothing in this document recommends, suggests, instructs, or endorses the use of any peptide, compound, injection technique, dosage, timing, frequency, or anatomical site. All information must be independently verified with a licensed medical professional. This document is intended to comply with applicable laws and regulations of the State of California.